158
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Association study of rs10768683 and rs968857 polymorphisms with transfusion-dependent thalassemia (TDT) in a southern Iranian population

, , , &
Pages 88-99 | Received 29 Mar 2018, Accepted 29 Jun 2018, Published online: 08 Mar 2019

References

  • Turner, A.; Sasse, J.; Varadi, A. Rapid detection of pathological mutations and deletions of the Haemoglobin Beta Gene (HBB) by High Resolution Melting (HRM) Analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR). BMC Med. Genet. 2016, 17, 75.
  • Galanello, R.; Origa, R. Beta-thalassemia. Orphanet. J. Rare Dis. 2010, 5, 11.
  • Derakhshandeh-Peykar, P.; Akhavan-Niaki, H.; Tamaddoni, A.; Ghawidel-Parsa, S.; Naieni, K. H.; Rahmani, M.; Babrzadeh, F.; Dilmaghani-Zadeh, M.; Farhud, D. D. Distribution of beta-thalassemia mutations in the Northern Provinces of Iran. Hemoglobin 2007, 31, 351–356.
  • Habibzadeh, F. Thalassemia in Iran; An overview. Arch. Iran Med. 1998, 1, 27–33.
  • Hilliard, L. M.; Berkow, R. L. The thalassemia syndromes. Primary Care Update OB/GYNS 1996, 3, 157–162.
  • Piel, F. B.; Weatherall, D. J. The α-thalassemias. N. Engl. J. Med. 2014, 371, 1908–1916.
  • Muncie, H. L.; Jr.; Campbell, J. Alpha and beta thalassemia. Am. Fam. Physician 2009, 80, 339–344.
  • Cappellini, M. I09 thalassemia syndromes. Blood Rev. 2007, 21, S34–S35.
  • Cao, A.; Galanello, R. Beta-thalassemia. Genet. Med. 2010, 12, 61–76.
  • Viprakasit, V.; Ekwattanakit, S. Clinical classification, screening and diagnosis for thalassemia. Hematol./Oncol. Clin. N. Am. 2018, 32, 193–211.
  • Zafari, M.; Kowsaryan, M.; Gill, P.; Banihashemi, A. Non invasive prenatal diagnosis of β-thalassemia, a narrative review study. Bangladesh J. Med. Sci. 2017, 16, 196–202.
  • Devers, P. L.; Cronister, A.; Ormond, K. E.; Facio, F.; Brasington, C. K.; Flodman, P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. J. Genet. Counsel. 2013, 22, 291–295.
  • Cappellini, M.-D.; Cohen, A.; Porter, J.; Taher, A.; Viprakasit, V. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT); Thalassaemia International Federation: Nicosia (CY), 2014.]
  • Eleftheriou, A. Guidelines for the Management of Nontransfusion Dependent Thalassaemia (NTDT); Thalassaemia International Federation: Nicosia, CY, 2007.
  • Tischler, R.; Hudgins, L.; Blumenfeld, Y. J.; Greely, H. T.; Ormond, K. E. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat. Diagn. 2011, 31, 1292–1299.
  • Lench, N.; Barrett, A.; Fielding, S.; McKay, F.; Hill, M.; Jenkins, L.; White, H.; Chitty, L. S. The clinical implementation of non‐invasive prenatal diagnosis for single‐gene disorders: challenges and progress made. Prenat. Diagn. 2013, 33, 555–562.
  • Lam, K.-W. G.; Jiang, P.; Liao, G. J. W.; Chan, K. C. A.; Leung, T. Y.; Chiu, R. W. K.; Lo, Y. M. D. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. Clin. Chem. 2012, 58, 1467–1475.
  • Papasavva, T.; Kalikas, I.; Kyrri, A.; Kleanthous, M. Arrayed primer extension for the noninvasive prenatal diagnosis of β‐thalassemia based on detection of single nucleotide polymorphisms. Ann. N. Y. Acad. Sci. 2008, 1137, 302–308.
  • Ayatollahi, M.; Merat, A.; Haghshenas, M. Ava II site as a marker of β-globin gene polymorphism, among normal and sickle cell patients in Iran. Iran. Biomed. J. 2001, 5, 117–119.
  • Shaikho, E. M.; Farrell, J. J.; Alsultan, A.; Qutub, H.; Al-Ali, A. K.; Figueiredo, M. S.; Chui, D. H. K.; Farrer, L. A.; Murphy, G. J.; Mostoslavsky, G.; et al. A phased SNP-based classification of sickle cell anemia HBB haplotypes. BMC Genomics 2017, 18, 608.
  • Papasavva, T.; van IJcken, W. F. J.; Kockx, C. E. M.; van den Hout, M. C. G. N.; Kountouris, P.; Kythreotis, L.; Kalogirou, E.; Grosveld, F. G.; Kleanthous, M. Next generation sequencing of SNPS for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia. Eur. J. Hum. Genet. 2013, 21, 1403–1410.
  • Akinsheye, I.; Alsultan, A.; Solovieff, N.; Ngo, D.; Baldwin, C. T.; Sebastiani, P.; Chui, D. H. K.; Steinberg, M. H. Fetal hemoglobin in sickle cell anemia. Blood 2011, 118, 19–27.
  • Bailey, J. W.; Williams, J.; Bain, B. J.; Parker-Williams, J.; Chiodini, P. L. Guideline: the laboratory diagnosis of malaria. General Haematology Task Force of the British Committee for Standards in Haematology. Br. J. Haematol. 2013, 163, 573–580.
  • De Sanctis, V.; Elsedfy, H. Clinical and biochemical data of adult Thalassemia Major Patients (TM) with Multiple Endocrine Complications (MEC) versus TM Patients with normal endocrine functions: a long-term retrospective study (40 Years) in a Tertiary Care Center in Italy. Mediterr. J. Hematol. Infect. Dis. 2016, 8, 2016022.
  • Little, S. Amplification‐Refractory Mutation System (ARMS) analysis of point mutations. Curr. Protocols Hum. Genetics 2001, 12, 9.8–1-9.8.
  • Kwok, S.; Kellogg, D. E.; McKinney, N.; Spasic, D.; Goda, L.; Levenson, C.; Sninsky, J. J. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 1990, 18, 999–1005.
  • Chiu, R. W. K.; Lau, T. K.; Leung, T. N.; Chow, K. C. K.; Chui, D. H. K.; Lo, Y. M. D. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002, 360, 998–1000.
  • Li, Y. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005, 293, 843–849.
  • Galbiati, S.; Foglieni, B.; Travi, M.; Curcio, C.; Restagno, G.; Sbaiz, L.; Smid, M.; Pasi, F.; Ferrari, A.; Ferrari, M.; et al. Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of β-thalassemia. Haematologica 2008, 93, 610–614.
  • Galbiati, S.; Brisci, A.; Lalatta, F.; Seia, M.; Makrigiorgos, G. M.; Ferrari, M.; Cremonesi, L. Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases. Clin. Chem. 2011, 57, 136–138.
  • Papasavva, T.; Kalakoutis, G.; Kalikas, I.; Neokli, E.; Papacharalambous, S.; Kyrri, A.; Kleanthous, M. Noninvasive prenatal diagnostic assay for the detection of beta-thalassemia. Ann. N. Y. Acad. Sci. 2006, 1075, 148–153. (
  • Old, J. M.; Petrou, M.; Modell, B.; Weatherall, D. J. Feasibility of antenatal diagnosis of beta thalassaemia by DNA polymorphisms in Asian Indian and Cypriot populations. Br. J. Haematol. 1984, 57, 255–263.
  • Motovali-Bashi, M.; Sajadpoor, Z.; Hajihoseini, S. Investigation of BamHI and AvaII polymorphisms at beta globin cluster gene and its association with beta thalassemia disease in Esfahan population. Res. Med. 2015, 38, 226–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.